ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | N216632 | BAUSCH HEALTH US LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BAUSCH HEALTH IRELAND LIMITED et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al 4 patentsANDA 220161clindamycin phosphate, adapalene, and benzoyl peroxide (1.2%/0.15%/3.1%) | D.N.J. | 2026-04-10 | Active | — |
BAUSCH HEALTH IRELAND LIMITED et al v. TARO PHARMACEUTICALS INC. et al 8 patentsANDA 220097clindamycin phosphate, adapalene, and benzoyl peroxide (1.2%/0.15%/3.1%) | D.N.J. | 2025-03-20 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Code | Date | Status |
|---|---|---|
| NP | Oct 20, 2026 | < 1 year |
Bausch added U.S. Patent 12,616,710 to the Orange Book listing for CABTREO (adapalene, benzoyl peroxide, clindamycin phosphate).
New: New record